PHA First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Similar documents
PHA First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall 2007

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Third Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name:

Case Study VI Answers PHA 5127 Fall 2006

Relation between Fourier Series and Transform

Single Correct Type. cos z + k, then the value of k equals. dx = 2 dz. (a) 1 (b) 0 (c)1 (d) 2 (code-v2t3paq10) l (c) ( l ) x.

Math 266, Practice Midterm Exam 2

Fourier Series and Parseval s Relation Çağatay Candan Dec. 22, 2013

(b) 10 yr. (b) 13 m. 1.6 m s, m s m s (c) 13.1 s. 32. (a) 20.0 s (b) No, the minimum distance to stop = 1.00 km. 1.

Fourier. Continuous time. Review. with period T, x t. Inverse Fourier F Transform. x t. Transform. j t

PHA 5127 Answers Homework 2 Fall 2001

3.4 Repeated Roots; Reduction of Order

Boyce/DiPrima 9 th ed, Ch 2.1: Linear Equations; Method of Integrating Factors

Answer Homework 5 PHA5127 Fall 1999 Jeff Stark

AR(1) Process. The first-order autoregressive process, AR(1) is. where e t is WN(0, σ 2 )

Revisiting what you have learned in Advanced Mathematical Analysis

Jonathan Turner Exam 2-10/28/03

PHA 4123 First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

16.512, Rocket Propulsion Prof. Manuel Martinez-Sanchez Lecture 3: Ideal Nozzle Fluid Mechanics

The Procedure Abstraction Part II: Symbol Tables and Activation Records

PHA Final Exam Fall 2007

PHA 5128 Answer CASE STUDY 3 Question #1: Model

Engine Thrust. From momentum conservation

A L A BA M A L A W R E V IE W

Inverse Fourier Transform. Properties of Continuous time Fourier Transform. Review. Linearity. Reading Assignment Oppenheim Sec pp.289.

A THREE COMPARTMENT MATHEMATICAL MODEL OF LIVER

INTERQUARTILE RANGE. I can calculate variabilityinterquartile Range and Mean. Absolute Deviation

A Study of the Solutions of the Lotka Volterra. Prey Predator System Using Perturbation. Technique

Right Angle Trigonometry

The model proposed by Vasicek in 1977 is a yield-based one-factor equilibrium model given by the dynamic

Wave Phenomena Physics 15c

More on FT. Lecture 10 4CT.5 3CT.3-5,7,8. BME 333 Biomedical Signals and Systems - J.Schesser

UNIT # 08 (PART - I)

PHA Final Exam Fall 2001

FL/VAL ~RA1::1. Professor INTERVI of. Professor It Fr recru. sor Social,, first of all, was. Sys SDC? Yes, as a. was a. assumee.

ELECTRIC VELOCITY SERVO REGULATION

Pupil / Class Record We can assume a word has been learned when it has been either tested or used correctly at least three times.

PHYSICS 1210 Exam 1 University of Wyoming 14 February points

Case Study Vancomycin Answers Provided by Jeffrey Stark, Graduate Student

MATHEMATICS FOR MANAGEMENT BBMP1103

Lecture 21 : Graphene Bandstructure

Ch 1.2: Solutions of Some Differential Equations

Elementary Differential Equations and Boundary Value Problems

The general concept of pharmacokinetics

Multiple Short Term Infusion Homework # 5 PHA 5127

Chapter4 Time Domain Analysis of Control System

1 Finite Automata and Regular Expressions

Chapter 4 Circular and Curvilinear Motions

CS 688 Pattern Recognition. Linear Models for Classification

Systems of First Order Linear Differential Equations

Case Study 1 PHA 5127 Fall 2006 Revised 9/19/06

Charging of capacitor through inductor and resistor

EXERCISE - 01 CHECK YOUR GRASP

(A) 1 (B) 1 + (sin 1) (C) 1 (sin 1) (D) (sin 1) 1 (C) and g be the inverse of f. Then the value of g'(0) is. (C) a. dx (a > 0) is

CSE 373: AVL trees. Warmup: Warmup. Interlude: Exploring the balance invariant. AVL Trees: Invariants. AVL tree invariants review

T h e C S E T I P r o j e c t

EEE 303: Signals and Linear Systems

Erlkönig. t t.! t t. t t t tj "tt. tj t tj ttt!t t. e t Jt e t t t e t Jt

Adrian Sfarti University of California, 387 Soda Hall, UC Berkeley, California, USA

4.1 The Uniform Distribution Def n: A c.r.v. X has a continuous uniform distribution on [a, b] when its pdf is = 1 a x b

Midterm. Answer Key. 1. Give a short explanation of the following terms.

Chapter 8: Propagating Quantum States of Radiation

Motion. Part 2: Constant Acceleration. Acceleration. October Lab Physics. Ms. Levine 1. Acceleration. Acceleration. Units for Acceleration.

Midterm exam 2, April 7, 2009 (solutions)

Name:... Batch:... TOPIC: II (C) 1 sec 3 2x - 3 sec 2x. 6 é ë. logtan x (A) log (tan x) (B) cot (log x) (C) log log (tan x) (D) tan (log x) cos x (C)

Institute of Actuaries of India

Chapter 5 Transient Analysis

Laplace Transform. National Chiao Tung University Chun-Jen Tsai 10/19/2011

2 T. or T. DSP First, 2/e. This Lecture: Lecture 7C Fourier Series Examples: Appendix C, Section C-2 Various Fourier Series

EE415/515 Fundamentals of Semiconductor Devices Fall 2012

C From Faraday's Law, the induced voltage is, C The effect of electromagnetic induction in the coil itself is called selfinduction.

Derivation of the differential equation of motion

Section 2: The Z-Transform

Integration Continued. Integration by Parts Solving Definite Integrals: Area Under a Curve Improper Integrals

2D Motion WS. A horizontally launched projectile s initial vertical velocity is zero. Solve the following problems with this information.

2.1. Differential Equations and Solutions #3, 4, 17, 20, 24, 35

Average & instantaneous velocity and acceleration Motion with constant acceleration

Advanced Engineering Mathematics, K.A. Stroud, Dexter J. Booth Engineering Mathematics, H.K. Dass Higher Engineering Mathematics, Dr. B.S.

UNIT #5 EXPONENTIAL AND LOGARITHMIC FUNCTIONS

CSE 245: Computer Aided Circuit Simulation and Verification

NEW FLOODWAY (CLOMR) TE TE PIN: GREENS OF ROCK HILL, LLC DB: 12209, PG: ' S67 46'18"E APPROX. FLOODWAY NEW BASE FLOOD (CLOMR)

Spring 2006 Process Dynamics, Operations, and Control Lesson 2: Mathematics Review

e t dt e t dt = lim e t dt T (1 e T ) = 1

The order of reaction is defined as the number of atoms or molecules whose concentration change during the chemical reaction.

SAMPLE LITANY OF THE SAINTS E/G. Dadd9/F. Aadd9. cy. Christ, have. Lord, have mer cy. Christ, have A/E. Dadd9. Aadd9/C Bm E. 1. Ma ry and. mer cy.

A 1.3 m 2.5 m 2.8 m. x = m m = 8400 m. y = 4900 m 3200 m = 1700 m

Systems of First Order Linear Differential Equations

Contraction Mapping Principle Approach to Differential Equations

Functions and Graphs 1. (a) (b) (c) (f) (e) (d) 2. (a) (b) (c) (d)

Instructors Solution for Assignment 3 Chapter 3: Time Domain Analysis of LTIC Systems

On the Speed of Heat Wave. Mihály Makai

Section 3: Antiderivatives of Formulas

Major: All Engineering Majors. Authors: Autar Kaw, Luke Snyder

Floating Point Number System -(1.3)

Floating Point Number System -(1.3)

Transcription:

Nm: UFI#: PHA 5127 Firs Exm Fll 2014 On my honor, I hv nihr givn nor rcivd unuhorizd id in doing his ssignmn. Nm Qusion S/Poins I. 30 ps II. 20 ps III. 15 ps IV 15 ps V. 25 ps VI. 10 ps VII. 10 ps VIII. 10 ps IX. 35 ps TOTAL: 170 ps 1

Nm: UFI#: Qusion S I (Tru or Fls) (30 poins) Tru (A) or Fls (B). On h bubbl sh mr A for ru or B for fls. Assum pssiv diffusion s h driving forc for disribuion. 1: T F Th 1/2 of drug limind hrough zro ordr procss is drug spcific consn. 2: T F A lipophilic drug of low molculr wigh, cnno hv volum of disribuion h is smllr hn VT. 3: T F Th frcion of h drug bing limind pr hour is incrsing in firs ordr procss. 4: T F Two drugs h hv similr liminion hlf-livs will hv similr volums of disribuions. 5: T F Th sm dos of drug is givn orlly ihr s soluion or in form of slow dissolving crysl suspnsion. Th soluion will show highr mximum concnrions in plsm. 6: T F Whn hprin is ddd o blood nd h blood is cnrifugd, h rsuling suprnn is clld srum. 2

Nm: UFI#: Qusion S II (20 poins) Tru (A) or Fls (B). On h bubbl sh mr A for ru or B for fls. Tru (A) or Fls (B). On h bubbl sh mr A for ru or B for fls. onsidr lipophilic cidic drug A (p=14, logp=5, If you hv difficulis wih pk vlus: Th pk of Hl is clos o zro) nd lipophilic nurl drug B (logp=5). Boh do no show ny ffiniy o rnsporrs nd show similr issu nd plsm proin binding. 7: T F rug B will nr h brin fsr. 8: T F rug A will b unbl o nr h inrsiil fluid. 9: T F rug B b is lily o hv lrgr volum of disribuion 10: T F Th K of boh drugs will only diffr, if L diffrs. 3

Nm: UFI#: Qusion S III (15 poins) Lisd in h Tbl r wo propris of cidic drug molculs: h frcion unionizd ph=7.4 nd h priion cofficin of h unionizd form. RUG Frcion Unionizd Priion officin Molculr ph=7.4 of Unionizd form Wigh (lon) 1 0.6 3.1 240 2 0.91 0.1 290 3 0.074 10 320 4 0.72 0.005 456 11: Slc h corrc rn ordr wih which drugs 1-4 will nr brin issu. Assum h h drugs r no subjc o rnsporrs h blood-brin brrir. A) 1 slowr hn 2 slowr hn 3 slowr hn 4 B) 4 slowr hn 2 slowr hn 3 slowr hn 1 ) 4 slowr hn 2 slowr hn 1 slowr hn 3 ) 3 slowr hn 1 slowr hn 4 slowr hn 2 E) 1 slowr hn 3 slowr hn 2 slowr hn 4 4

Nm: UFI#: Qusion S IV (Tru or Fls) (15 poins) Tru (A) or Fls (B). On h bubbl sh mr A for ru or B for fls. Assum no civ rnspor. 12: T F Assum drug is subsr of spcific rnspor proin. Trnsporrs only limin drugs from h body 13: T F Th r wih which hydrophilic compounds will mov cross wll-buil mmbrns will dpnd on h concnrion grdin bwn ol drug in plsm nd ol drug in issu. 14: T F Assuming h proin drug dos no bind o plsm nd issu componn, h volum of disribuion is lily o b 41 lirs. 5

Nm: UFI#: Qusion S V (Tru or Fls) (25 poins) onc. (ng/ml) 100.00 10.00 1.00 0.10 0.01 0 1 2 3 4 5 6 7 8 9 10 Tim (h) onc. (ng/ml) 22 20 18 16 14 12 10 8 6 4 2 0 0 1 2 3 4 5 6 7 8 9 10 Tim (h) rug A rug B Tru (A) or Fls (B). On h bubbl sh mr A for ru or B for fls 15: T F rug B s r of liminion is ffcd by h moun of drug in h body. 16: T F rug A s liminion r consn hs h uni ng/ml. 17: T F For drug B, h frcion of drug limind pr hour is consn. 18: T F rug A s concnrion-im profil migh b xplind by surd mbolic nzyms. 19: T F For drug A, h liminion r consn dos no dpnd on h moun of drug in h body. 6

Nm: UFI#: Qusion S VI (10 poins) 20: An invsigionl nw drug is limind nirly by hpic mbolism, wih clrnc of 1 L/h in hlhy subjcs. Assum n vrg livr blood flow of 80 L/h in hs hlhy subjcs. Wh would b h xpcd clrnc in congsiv hr filur pin wih livr blood flow of 66 L/h? Us h mos ppropri rlionships A) 0.83 L/h B) 1.0 L/h ) 0.66 L/h ) 66 L/h E) Non of h bov 7

Nm: UFI#: Qusion S VI 21: A drug hs n inrinsic clrnc of 40,000 L/min. Th plsm proin binding nd livr blood flow r 60% nd 80 L/h, rspcivly. lcul h hpic clrnc. A) 80 L/h B) 35 L/h ) 48 L/h ) 320 L/h E) Non of h bov 8

Nm: UFI#: Qusion S VII (10 poins) 22: Assum drug A is prdominnly clrd hrough hpic mbolism. rug A hs n inrinsic clrnc of 40,000 L/min. Th plsm proin binding nd livr blood flow r 60% nd 80 L/h, rspcivly. How will h incrs in boh issu binding nd livr blood flow ffc h iniil concnrion (0 whn givn s i.v. bolus), hpic clrnc (L), biovilbiliy (F) for bl, AU, nd hlf-lif (1/2)? (Pls no h mns: bou h sm) A) 0, L, F, AU, 1/2 B) 0, L, F, AU, 1/2 ) 0, L, F, AU, 1/2 ) 0, L, F, AU, 1/2 E) 0, L, F, AU, 1/2 9

Nm: UFI#: Qusion S VIII (10 poins) 23. A nw nlysis chniqu hs nbld you o msur h drug concnrion bfor nd fr h blood psss h livr. Th plsm concnrions bfor nd fr h livr ws pssd wr 6.5 nd 2.4 mg/ml, rspcivly. lcul h hpic clrnc (ssum livr blood flow of 1450 ml/min). A) 15 L/h B) 35 L/h ) 55 L/h ) 75 L/h E) Non of bov 10

Nm: UFI#: Qusion S IX (35 poins) Mr A for Tru or B for Fls 24: T F Fr drug concnrions r lwys h sm in plsm nd issus, whn h disribuion occurs insnnously. 25: T F Enzym inducion ffcs h hpic clrnc of low nd high xrcion drugs 26: T F Enzym inducion ffcs h orl biovilbiliy of high xrcion drugs 27: T F A fs bsorpion migh llow lss frqun dosing. 28: T F A slowr bsorpion migh b dvngous for drug wih nrrow hrpuic window. 29: T F Th Fic s lw is: dq/d=*k*(plsm-issu)/h. Th concnrion rms (plsm nd issu )rfr o ol drug concnrions in ihr plsm or issu. 30: T F oncnrions in plsm r of rlvnc for drug hrpy s hy gnrlly corrl wll wih concnrions obsrvd h ffc (rg) si. 11

Nm: UFI#: 12

Nm: UFI#: 13

Symbols Usful Phrmcoinic Equions = dos = dosing inrvl L = clrnc Vd = volum of disribuion = liminion r consn = bsorpion r consn F = frcion bsorbd (biovilbiliy) K 0 = infusion r T = durion of infusion = plsm concnrion Gnrl Eliminion r consn 1 ln L Vd 2 ln ln 2 1 1 2 2 1 Hlf-lif 0. 693 Vd ln( 2) 0. 693 12 / L Inrvnous bolus Trough (mulipl dos) 0 min 1 Avrg concnrion (sdy s) pss L Orl dminisrion Plsm concnrion (singl dos) F Vd Tim of mximum concnrion (singl dos) ln mx Plsm concnrion (mulipl dos) F Vd 1 1 Iniil concnrion 0 Vd Plsm concnrion (singl dos) 0 Plsm concnrion (mulipl dos) 0 1 P (mulipl dos) 0 mx 1 Tim of mximum concnrion (mulipl dos) 1 ln 1 mx Avrg concnrion (sdy s) F L lrnc os F l AU l V d Equions/Usful_phrmcoinic_qu_5127 1

onsn r infusion Plsm concnrion (during infusion) 0 1 L Plsm concnrion (sdy s) 0 L lculd clrnc (hiou quion) 2 2 Vd 0 1 2 L 1 2 1 2 2 1 Shor-rm infusion P (singl dos) mx( 1) 1 LT T Trough (singl dos) T min( 1) mx( 1) P (mulipl dos) mx LT 1 1 T Trough (mulipl dos) lculd p mx mx wih mx * = msurd p, msurd im * fr h nd of h infusion lculd rough min min wih min * = msurd rough, msurd im * bfor h sr of h nx infusion lculd volum of disribuion Vd T [ mx 1 T T ( min )] lculd rcommndd dosing inrvl ln mx( dsird ) min( dsird ) T lculd rcommndd dos VT mx( dsird ) 1 1 T Two-omprmn-Body Modl T min mx lculd liminion r consn mx ln min wih * mx = msurd p nd * min = msurd rough, msurd ovr h im inrvl b Equions/Usful_phrmcoinic_qu_5127 2 AU / b / Vd Vd Vc r rinin lrnc L L cr cr ss ( 140 g) wigh ( ml) 72 p cr ( 140 g) wigh ( fml) 85 p cr Wih wigh in g, g in yrs, crinin plsm conc. in mg/dl nd L cr in ml/min

K for minoglycosids K = 0.00293(rL) + 0.014 Mbolic nd Rnl lrnc E H = lin fub Q l fu H in b l H = E Q = H H QH lin fub Q l fu H in b F H = Q H Q H l in fu b l rn = RBFE = GFR in in ou l rn = l rn = l rn = r of xcrion plsm concnrion R of scrion - R of rbsorpion fu GFR Plsm concnrion Urin flow urin concnrion Plsm concnrion Idl Body Wigh Ml IBW = 50 g + 2.3 g for ch inch ovr 5f in high Fml IBW = 45.5 g + 2.3 g for ch inch ovr 5f in high Obs ABW = IBW + 0.4*(TBW-IBW) Volum of isribuion V V P V V P lrnc l os AU l V d V V T T K P fu fu T Equions/Usful_phrmcoinic_qu_5127 3

For On omprmn Body Modl If h dosing involvs h us of I.V. bolus dminisrion: For singl I.V. bolus dminisrion: 0 V 0 For mulipl I.V. bolus dminisrion: n 1 n( ) V 1 p: = 0; sdy s n rough: = mx ss 1 V ( 1 ) min ss mx ss If h dosing involvs h us of I.V. infusion: For singl shor-rm I.V. infusion: Sinc = for mx T 1 mx min VT mx ( T ) For mulipl shor-rm I.V. infusion sdy s: T 1 mx V T 1 min mx ( T ) Ls modifid 2010 :\urrn \ph5127_os_op_i\quions\5127-28-quions.doc

Ls modifid 2010 :\urrn \ph5127_os_op_i\quions\5127-28-quions.doc If h dosing involvs I.V. infusion (mor quions): T T V 1 (mos gnrl q.) during infusion = T so, T V 1 (during infusion) sdy s, -, 0 so, L V T V pss 0 0 (sdy s) rmmbring T 0 nd V L If h dosing involvs orl dminisrion: For singl orl dos: V F 1 ln mx For mulipl orl doss: V F 1 1 1 1 1 ln mx